Your account is not claimed yet. You can sign up with ORCID to claim your account.

Michael J Donovan (Michael Donovan)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Venues

Prostate cancer and prostatic diseases

Science advances

BMC urology

Clinical proteomics

Icahn School of Medicine at Mt. Sinai

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Icahn School of Medicine at Mt. Sinai

United States

Professor :: Pathology

Publications

Ronald Tutrone, Ben Lowentritt, Brian Neuman, Michael J Donovan, Elliot Hallmark, T Jeffrey Cole, Yiyuan Yao, Claire Biesecker, Sonia Kumar, Vinita Verma, Grannum R Sant, Jason Alter, Johan Skog
ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis. Prostate cancer and prostatic diseases (2023)
Ronald Tutrone, Ben Lowentritt, Brian Neuman, Michael J Donovan, Elliot Hallmark, T Jeffrey Cole, Yiyuan Yao, Claire Biesecker, Sonia Kumar, Vinita Verma, Grannum R Sant, Jason Alter, Johan Skog
Correction to: ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis. Prostate cancer and prostatic diseases (2023)
Joji Tokita, Aida Vega, Catherine Sinfield, Nidhi Naik, Shivani Rathi, Sharlene Martin, Stephanie Wang, Leonard Amoruso, Azadeh Zabetian, Steven G Coca, Girish N Nadkarni, Fergus Fleming, Michael J Donovan, Robert Fields
Real World Evidence and Clinical Utility of KidneyIntelX on Patients With Early-Stage Diabetic Kidney Disease: Interim Results on Decision Impact and Outcomes. Journal of primary care & community health 13 (2022)
Lili Chan, Girish N Nadkarni, Fergus Fleming, James R McCullough, Patricia Connolly, Gohar Mosoyan, Fadi E Salem, Michael W Kattan, Joseph A Vassalotti, Barbara Murphy, Michael J Donovan, Steven G Coca, Scott M Damrauer
Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease. Diabetologia 64 (7) (2021)
Patricia Connolly, Sharon Stapleton, Gohar Mosoyan, Ilya Fligelman, Ya-Chen Tonar, Fergus Fleming, Michael J Donovan
Analytical validation of a multi-biomarker algorithmic test for prediction of progressive kidney function decline in patients with early-stage kidney disease. Clinical proteomics 18 (1) (2021)
Erik Margolis, Gordon Brown, Alan Partin, Ballentine Carter, James McKiernan, Ronald Tutrone, Phillipp Torkler, Christian Fischer, Vasisht Tadigotla, Mikkel Noerholm, Michael J Donovan, Johan Skog
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies. Prostate cancer and prostatic diseases (2021)
James McKiernan, Mikkel Noerholm, Vasisht Tadigotla, Sonia Kumar, Phillipp Torkler, Grannum Sant, Jason Alter, Michael J Donovan, Johan Skog
A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy. BMC urology 20 (1) (2020)
Erdem Bangi, Celina Ang, Peter Smibert, Andrew V Uzilov, Alexander G Teague, Yevgeniy Antipin, Rong Chen, Chana Hecht, Nelson Gruszczynski, Wesley J Yon, Denis Malyshev, Denise Laspina, Isaiah Selkridge, Hope Rainey, Aye S Moe, Chun Yee Lau, Patricia Taik, Eric Wilck, Aarti Bhardwaj, Max Sung, Sara Kim, Kendra Yum, Robert Sebra, Michael J Donovan, Krzysztof Misiukiewicz, Eric E Schadt, Marshall R Posner, Ross L Cagan
A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer. Science advances 5 (5) (2019)
Michael J Donovan, Carlos Cordon-Cardo
Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes. Molecular diagnosis & therapy 21 (2) (2017)

Michael J Donovan.css-eqlu8i{font-size:small;padding-left:4px;} (Michael Donovan)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael J Donovan (Michael Donovan)